Taking a Stand for Patients
Who We Are
The Alliance for Transparent & Affordable Prescriptions (ATAP) is a coalition of patient and provider organizations functioning at both the state and national level who have joined together to address pharmacy benefit managers (PBMs) and their impact on prescription drug costs and patient access to affordable treatment.
The US Senate Finance Committee is upping the ante on the issue of drug pricing with yet another hearing — this time with pharmacy benefit managers.
During this 28 minute conversation, Dr. Levin discusses ATAP's mission and funding and ATAP's position on the administration's current proposal to reform Medicare Part B drug pricing via reference pricing or via the use of an international price index. Dr. Levin discusses moreover the administration's current proposal to reform Medicare Part D drug pricing by eliminating or prohibiting drug manufacturers from paying a rebate to pharmaceutical benefit managers (PBMs) and Part D plan sponsors. This conversation concludes with Dr. Levin's comments concerning the long standing debate whether the Secretary of DHHS should be allowed to negotiate Part D drug prices with manufacturers.
